Invention Grant
- Patent Title: Oxadiazole compounds
-
Application No.: US15122959Application Date: 2015-03-17
-
Publication No.: US10562869B2Publication Date: 2020-02-18
- Inventor: Gerard Griffioen , Bart De Taeye , Katrien Princen , Koen De Witte , Emilie Blanche , Hasane Ratni , Matthias Nettekoven , Mark Rogers-Evans
- Applicant: REMYND NV
- Applicant Address: BE Heverlee
- Assignee: REMYND NV
- Current Assignee: REMYND NV
- Current Assignee Address: BE Heverlee
- Agency: Amster, Rothstein & Ebenstein LLP
- Priority: EP14160354 20140317
- International Application: PCT/EP2015/055488 WO 20150317
- International Announcement: WO2015/140130 WO 20150924
- Main IPC: C07D271/07
- IPC: C07D271/07 ; A61K31/496 ; C07D413/12 ; C07D471/10

Abstract:
The present invention relates to a compound of formula (I) or (II) or a stereoisomer, enantiomer, racemic, or tautomer thereof, (I) (II) wherein R1, R2, R3, L1, L2, L3, L4, L5 and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
Public/Granted literature
- US20170073319A1 OXADIAZOLE COMPOUNDS Public/Granted day:2017-03-16
Information query